News & Updates

Show Multimedia Only

T-DXd plus RT shows promise in management of metastatic breast cancer

09 Jan 2026

Combination treatment with trastuzumab deruxtecan (T-DXd) and radiation therapy (RT) may improve clinical outcomes, without compromising safety, in patients with HER2-positive and HER2-low metastatic breast cancer, reveals a study.

T-DXd plus RT shows promise in management of metastatic breast cancer

09 Jan 2026

Ropeginterferon alfa-2b fares well for ET in ROP-ET trial

09 Jan 2026 by

The results from the phase III ROP-ET trial demonstrate the potential of ropeginterferon alfa-2b (ropeg) for the treatment of essential thrombocythaemia (ET) across all risk levels in patients who are ineligible for standard cytoreduction.

Ropeginterferon alfa-2b fares well for ET in ROP-ET trial

09 Jan 2026

Intravenous thrombolysis safe, beneficial for stroke patients with recent DOAC use

09 Jan 2026

In the treatment of acute ischaemic stroke in patients with recent direct oral anticoagulant (DOAC) use, intravenous thrombolysis appears to be safe and is associated with improvements in functional outcomes, according to a study.

Intravenous thrombolysis safe, beneficial for stroke patients with recent DOAC use

09 Jan 2026

IV iron lowers mortality risk in anaemics

09 Jan 2026 by

A retrospective study spanning 25 years has shown that intravenous (IV) iron therapy in hospitalized patients with iron-deficiency anaemia and acute infections is associated with a lower risk of death.

IV iron lowers mortality risk in anaemics

09 Jan 2026

Dietary carotenoids, flavonoids mitigate risk of frailty in old age

08 Jan 2026 by

Sticking to a dietary pattern high in carotenoids and flavonoids during middle age helps prevent the development of frailty later in life, according to a study from Singapore.

Dietary carotenoids, flavonoids mitigate risk of frailty in old age

08 Jan 2026

OAB symptoms may increase in breast cancer patients undergoing chemotherapy

08 Jan 2026

Symptoms of overactive bladder (OAC) tend to rise among women receiving both trastuzumab and pertuzumab for HER2-positive positive breast cancer during their treatment, reports a study.

OAB symptoms may increase in breast cancer patients undergoing chemotherapy

08 Jan 2026

Tirzepatide delivers real-world benefits, safety in T2D patients in India

08 Jan 2026 by

A real-world assessment of tirzepatide in Indian clinical practice has shown significant glycaemic and weight benefits in adults with type 2 diabetes (T2D). The medication is also well tolerated, with manageable gastrointestinal side effects, and highly accepted by patients.

Tirzepatide delivers real-world benefits, safety in T2D patients in India

08 Jan 2026

Which social determinant predicts MASLD prevalence, severity?

08 Jan 2026

Among several social determinants of health (SDOHs), diet quality is most consistently associated with disease prevalence and severity in metabolic dysfunction-associated steatotic liver disease (MASLD), reports a study.